ABSTRACT
INTRODUCTION
The sexual health of gay, bisexual and other men who have sex with men (MSM) is often compromised by the presence of sexually transmitted infections (STIs) other than HIV, notably warts, syphilis, gonorrhoea and chlamydia. Syphilis and rectal bacterial STIs in particular, but also anal warts, are known to increase the risk of infection with HIV. [1] [2] [3] Early detection of asymptomatic STIs requires routine screening of MSM with changing sexual partners, including specimen collection 4 (or, for anal warts physical examination), allowing for detection of infections at sites common to men's same sex practices. Across Europe diagnostic services and healthcare for STIs exist within general practices and a variety of medical specialties (eg, urology and dermatovenereology) and are delivered in a range of settings (physicians in private practice, genitourinary medicine (GUM) clinics, specialised STI services within hospitals or dermatology clinics and municipal health offices). All these sites differ with respect to fees, visibility/accessibility and the services provided. The UK, Ireland, Malta and Sweden-through their respective national health systems-all provide a network of free and open access sexual health clinics. In many other European countries, physicians in private practice, including physicians specialised in infectious diseases and HIV care, play an important role in STI care. In most of the countries where the private sector plays a significant role, open access STI care is offered through municipal health offices. 5 In large cities over the last decade, there has been an increasing number of STI services targeted at MSM and tailored to their needs (eg, Amsterdam, Barcelona, Geneva, Dublin, Hamburg, London, Stockholm and Zurich 6 ). However, with the advent of rapid point-of-care tests, most of these venues have been set up primarily as HIV testing sites for MSM. The extent of additional STI services is variable and often restricted to serologically detectable STIs (eg, syphilis).
We carried out a Europe-wide MSM internet survey to compare the performance of STI services used by MSM, the largest and most comparable data yet available on this subject.
METHODS
The detailed methods of European MSM Internet Survey (EMIS) have been reported elsewhere. 7 In brief, EMIS was an anonymous, self-administered online survey conducted simultaneously in 25 languages across 38 countries. Participants were recruited through more than 230 social media or dating websites for MSM. Typical completion time was 20 min (calculated from the precise completion time for each survey and auto-captured by the survey software). No financial incentives were given. No IP addresses were collected. The survey was accessible online from June 6 to 31 August 2010. More background information, including the English version of the questionnaire, is available at http://www. emis-project.eu.
Measures
All men were asked about their access to STI testing and the time since their last STI test. Men who had tested in the last 12 months were asked about the presence or absence of symptoms at their last STI test, and which of the six diagnostic procedures were used (blood test, urine sample, penile examination, urethral swab, anal examination, anal swab). Questions were phrased in plain language avoiding specialist medical terms.
Inaccessibility was defined as not knowing whether free or affordable STI testing was available.
STI screening was defined as the last STI test being in the absence of symptoms. The six procedures were collapsed into four: blood test was defined as having 'provided a blood sample'; genital test was having had 'provided a urine sample' or 'something inserted into your penis'; inspection was defined as having had 'your penis' and 'your anus examined'; and anal swab was defined as having had 'something inserted into the anus (anal swab)'.
Statistical analysis
To compare across cities the odds of experiencing inaccessible services and undergoing the four procedures, we applied five individual-level multivariable logistic regression analyses (SPSS V.20, IBM Corporation, New York, USA) with stepwise inclusion of variables, controlling for age (<25; 25-39; ≥40), main recruitment website (PlanetRomeo vs others) and HIV diagnosis (diagnosed positive vs untested/last test negative).
Because perceived accessibility of services was likely to be higher among respondents who had used services, the odds for accessibility were controlled for time since STI test (never, over 12 months ago, within last 12 months). With respect to the four diagnostic procedures, we controlled for the number of sexual partners in the last 12 months (none, 1, 2-5, 6-10, ≥11), to ensure that the differences in intervention performance observed between cities were not confounded by differences in numbers of sexual partners in the respective subsamples. In recognition that STI testing in most countries is organised at a city level, we chose cities and not countries as units of comparison in the multivariable logistic regression analyses, choosing London as the reference. European cities were defined by selfreported postal code or subregion of residence, combined with settlement size. Forty large (500 000 inhabitants or more) European cities or country capitals were included in the analysis. Nagelkerke's R 2 was calculated to determine the degree of variance explained by the five variables included in the model. 
RESULTS Respondents

STI screening and diagnostic procedures
STI screening (in the last 12 months) ranged from 8.9% in Istanbul to 48.0% in Amsterdam (median 39.7%). The most common diagnostic procedure was a blood test (featured in more than 85% of screenings in all cities, median proportion 92.1%).
Diagnostic approaches to detect bacterial infections of the male urethra were less common (median 48.7% of screenings): 24.8% in Belgrade, 26.8% in Lyon and less than 40% of screens in Athens, Barcelona, Budapest, Milan, Paris, Sofia, Valencia and Warsaw included a urethral swab or urine sample. Only in Amsterdam, Birmingham, Dublin, Helsinki, London, Manchester, Oslo and Stockholm, were genital tests as common as blood tests (88%-98%).
The city median proportion reporting a physical inspection of anus and penis was 17.9%, and varied from 6.4% in Bucharest and less than 10% in Belgrade, Brussels, Lyon, Paris, Sofia and Valencia to more than 50% in Amsterdam, Birmingham, London, Manchester, Oslo and Stockholm, up to 70.7% in Dublin. The city median for the proportion of screens that included anal swabbing was 16.1%, and varied from 3.6% in Belgrade and less than 10% in Brussels, Bucharest, Istanbul, Paris and Warsaw, to more than 50% in Birmingham, Dublin, London, Manchester, Oslo and Stockholm, up to 72.4% in Amsterdam.
Multivariable logistic regression analyses
In multivariable logistic regression analysis, the adjusted odds for receiving the four diagnostic procedures (without the condition of being screened) steadily increased with the number of sexual partners in the last 12 months and were up to four times higher for men with diagnosed HIV. Compared with men aged 25-39 years, younger and older men were less likely to report any STI testing (table 1) . (1) Per cent recruited through individual message on PlanetRomeo; (2) Per cent under 25 years of age, Per cent aged 40 years or more; (3) Per cent with diagnosed HIV; (4) Per cent with more than 10 sex partners in the last 12 months; (5) Per cent tested in the absence of symptoms for STIs other than HIV in the last 12 months; (6) Per cent who did not know whether STI testing is for free or affordable where they live. Among those screened for STIs in the last 12 months, (7) Per cent having provided blood, (8) Per cent having provided urine sample or had something inserted into their penis, (9) Per cent having had their penis and anus inspected, (10) Per cent having had something inserted into their anus (anal swab). AOR, Adjusted OR for (7-10) the effect size is combined for being screened for STIs and having undergone the respective diagnostic procedure; Statistical significance: AOR was significantly different from 1 ( R =Reference) with p≤0.001 unless marked otherwise: *p>0.5;°p >0.1; ** p>0.05; *** p>0.01. STI, sexually transmitted infection; n.a., not applied.
Blood test
When adjusting for the previously described variables, the rate of blood tests in the last 12 months did not significantly differ in Amsterdam ( p=0.012), Manchester ( p=0.220), Moscow ( p=0.172) or Oslo ( p=0.056) compared with London. In all other cities, men were less likely to have received a blood test (median AOR=0.50). Cities with AORs at or below the median were Athens, Belgrade, Budapest, Cologne/Bonn, Hamburg, Helsinki, Kiev, Lisbon, Ljubljana, Munich, Porto, Prague, Riga, Rome, Tallinn, Sofia, Valencia, Vienna and Warsaw, and was least common in Istanbul (AOR=0.15).
Genital test
The adjusted odds for receiving a genital test were not significantly different from London for men in Amsterdam ( p=0.901), Birmingham ( p=0.501) or Manchester ( p=0.714). In all other cities, men were less likely to have received a genital test (median AOR=0.23). Cities with AORs at or below the median were Athens, Barcelona, Belgrade, Berlin, Brussels, Bucharest, Budapest, Cologne/Bonn, Hamburg, Ljubljana, Lyon, Milan, Munich, Paris, Porto, Rome, Sofia, Valencia and Warsaw, and was least common in Istanbul (AOR=0.09).
Inspection
The adjusted odds for receiving a genital/anal inspection were not significantly different from London for men in Amsterdam ( p=0.189), Dublin ( p=0.413), Manchester ( p=0.062) or Stockholm ( p=0.415). In all other cities, men were less likely to have received a penile and anal inspection (median AOR=0.14). Cities with AORs at or below the median were Athens, Barcelona, Brussels, Cologne/Bonn, Kiev, Lisbon, Lyon, Madrid, Milan, Munich, Paris, Porto, Riga, Rome, Sofia, Tallinn, Valencia and Warsaw, and was least common in Belgrade, Bucharest and Istanbul (AOR=0.06).
Anal swab
The adjusted odds for receiving anal swabbing were not significantly different from London for men in Amsterdam ( p=0.134) or Manchester ( p=0.119). In all other cities, men were less likely to have received anal swabbing (median AOR=0.09).
Cities with AORs at or below the median were Athens, Barcelona, Brussels, Bucharest, Budapest, Cologne/Bonn, Kiev, Lisbon, Lyon, Milan, Munich, Paris, Porto, Riga, Rome, Sofia, Valencia, Warsaw and Zurich, and was least common in Belgrade and Istanbul (AOR=0.02).
At city level, AORs for having received an anal swab and for having had an anal and penile inspection showed an almost perfect correlation (R 2 =94.3%), suggesting that STI testing sites either offer none or both (figure 2). In summary, offering anal swabs for the detection of rectal bacterial STIs and physical inspections of penis and anus were best in UK cities, Dublin, Amsterdam, Oslo and Stockholm, followed by Copenhagen and Figure 1 City-level analysis. Rates of STI screening as a function of inaccessibility of STI testing services in 40 European major cities. Figure 2 City-level analysis of 40 European cities. Adjusted OR (AOR) for a physical examination for sexually transmitted infections (inspection of anus and penis) versus AOR for having received an anal swab ('As part of an STI-test in the last 12 months, has something been inserted into the opening of your anus? (Anal Swab)').
Helsinki, and exceptional among Italian cities, Turin. An intermediate performance was reported from Ljubljana, Vienna, Berlin, Moscow and St Petersburg. In all other cities compared with London, men were 6-17 times less likely to have had their genitals and anus inspected, and 10-50 times less likely to have received an anal swab. Low performance could be demonstrated for a culturally and geographically broad spectrum of cities such as Belgrade, Brussels, Istanbul, Lisbon, Paris, Sofia, Valencia and Warsaw.
DISCUSSION
Accessible medical services and adequate diagnostic procedures are important dimensions of healthcare. 8 This is the first study to compare the accessibility of STI screening, STI screening rates and STI testing procedures for MSM across European cities.
Both accessibility and testing rates varied considerably across cities and demographic groups. Respondents' lack of clarity about charges for STI screening may be a function of the variety of STI testing and care services available, even within countries, 5 each with different policies and prices. A first step towards comprehensive STI testing for MSM could be to increase awareness of current services and, where unavailable, to establish accessible testing sites.
However, accessible services and regular testing do not guarantee that STIs are comprehensively diagnosed and treated. Gonococcal infections of the male urethra are typically symptomatic, 9 presenting with discharge and painful urination, and therefore, do not require further diagnostics apart from inspection of the penis and taking a medical history, unless bacterial resistance or bacterial coinfection ( particularly Chlamydia trachomatis) are suspected. Given that a blood test was almost universally performed upon STI testing, it is likely that STIs diagnosed with blood-based tests (syphilis and viral hepatitis) are detected among MSM who regularly test for STIs. However, a blood test alone does not constitute a sexual health screening, and a range of asymptomatic STIs will remain undiagnosed if this is the only procedure performed. These include urethral Chlamydia infections whose detection require nucleic acid amplification tests (NAAT) from urine samples or from urethral swabs, and rectal infections with C trachomatis or Neisseria gonorrhoea, 9 10 requiring microbiological culturing (gonorrhoea) or NAAT from anal swabs. 11 Manifestations of viral infections such as anal or genital warts, or anal or genital herpes can only be diagnosed if both penis and anus are inspected. Anal/genital warts may remain untreated if inspection of genitals and anus is not part of STI screening.
Unlike chlamydial infections of the oropharynx, pharyngeal gonorrhoea is very common following oral sex between men, 9 10 providing another reservoir for onward transmission. However, we did not query diagnostic approaches for detecting pharyngeal gonorrhoea.
In EMIS, the cities with the highest number of gay social and sexual venues reported to be visited were Berlin, Brussels, Cologne, Barcelona, Zurich, Madrid, Paris and Amsterdam. All these cities also attract international gay travellers. It is striking that with the exception of Amsterdam, these cities seem to lack the full spectrum of diagnostic approaches for asymptomatic STIs. Although some of these cities have established MSM-specific STI services, our findings suggest that the proportion of MSM reached by those services is not large enough to counterbalance the observed deficits. These deficits not only impact the sexual health of MSM, but also add to the problem of non-comparability of surveillance data 5 submitted to supra-national agencies such as the European Centre of Disease Prevention and Control.
Following the Ljubljana Gay Health Meeting on May 2008, a group of European non-governmental lesbian, gay, bisexual and trans and HIV/AIDS organisations published a call for tailored, individualised support and referral for HIV/STI testing and treatment, to be streamlined across Europe, with voluntary and anonymous testing services for STIs that are non-judgemental, gayfriendly and easily accessible by MSM. 12 The UK, Ireland and Sweden already have established networks of open access GUM clinics. 5 It is not feasible to change healthcare systems across Europe by introducing GUM clinics but, as demonstrated in Amsterdam, MSM-tailored services are possible even in countries where the healthcare system is highly privatised. 13 In the context of the changing epidemiology of STIs, increased mobility 14 15 and pan-European sexual networks, harmonised systems for the detection and monitoring of asymptomatic STIs are desirable. 5 
Limitations
Our self-reported data are subject to recall bias (and social desirability bias, which we think for this analysis is negligible). The four diagnostic procedures are constructs based on questions about what was done as part of STI testing; thus, the validity of what is called, for example, a genital test may be questioned. However, our survey pre-testing in a variety of languages showed that the non-medical language was appropriate and understood by respondents.
Due to the absence of denominator studies and sampling frames, representative random samples of MSM are impossible, so we rely on convenience samples. However, the Law of Large Numbers suggests that for the larger city samples, range is adequately represented. In this analysis, we compared performance of STI testing for MSM between cities, controlling only for variables likely to reflect recruitment biases (main recruitment site, age composition, 16 prevalence of diagnosed HIV 17 ). MSM populations in different European cities also differ with respect to migration status, sexual identity, outness, gay community attachment and the degree of legal, societal and institutional homophobia. 18 19 Although all these variables were substantially and significantly associated with the presented outcomes, we did not include them in the multivariable regression models, because they would mask the differences between cities. Nevertheless, they all contribute not only to the degree to which MSM are reached by targeted information, what they know about STI transmission or where and how frequently to present for STI testing, but also to the likelihood of disclosing their homosexual activity in the context of STI testing.
We acknowledge that unawareness about the affordability of STI testing is only one aspect of inaccessibility, as services could be available but MSM may not be aware of them. However, good policy in the provision of services includes raising awareness in the target groups. As the focus of this paper is not individual knowledge but performance of services, we felt that inaccessibility was the better term for this analysis.
CONCLUSION
Comprehensive diagnostic approaches can only be tailored to MSM if the individuals presenting for STI testing can be open about their sexuality. 20 To facilitate this disclosure, clinical staff requires skills in sexual history taking alongside positive attitudes to sexual diversity. 21 The heterogeneity of current STI diagnostic approaches hampers direct comparison of reported STI rates for MSM across Europe. High national levels of diagnosed STIs may reflect high levels of non-symptomatic screening and comprehensive diagnostic procedures as much as high levels of infections. A definition of standardised minimum diagnostic procedures could improve comparability of data arising from national surveillance systems, and aid in the design of effective public health responses.
Our data suggest that in most major European cities, anal/ genital warts and rectal gonorrhoea and Chlamydia infections are profoundly underdiagnosed among MSM. Inaccessibility of respective STI services in many cities further complicates the situation. There is an urgent need to implement or improve sexual healthcare tailored to MSM at risk for STIs.
Key messages
▸ This is the first city-level comparison of STI screening, service accessibility and comprehensiveness of screening among MSM across Europe. ▸ Asymptomatic STI screening in the last 12 months ranged from 8.9% (Istanbul) to 48.0% (Amsterdam) with city median of 39.7% and was inversely related to inaccessible services. ▸ In most cities, anal/genital warts and gonorrhoeal/ chlamydial rectal infections among MSM are likely to be profoundly underdiagnosed. ▸ There is an urgent need to increase the accessibility and comprehensiveness of STI screening for gay men and other MSM.
